Interplay of MiRNAs and Canonical Wnt Signaling Pathway in Hepatocellular Carcinoma

Overview

Journal Front Pharmacol

Date 2018 Jul 7

PMID 29977206

Citations 14

Authors

Xiaobo Nie

Yiran Liu

Wei-Dong Chen

Yan-Dong Wang

Affiliations

Soon will be listed here.

Abstract

Hepatocellular carcinoma is one of the leading causes of cancer death worldwide and the activation of canonical Wnt signaling pathway is universal in hepatocellular carcinoma patients. MicroRNAs are found to participate in the pathogenesis of hepatocellular carcinoma by activating or inhibiting components in the canonical Wnt signaling pathway. Meanwhile, transcriptional activation of microRNAs by canonical Wnt signaling pathway also contributes to the occurrence and progression of hepatocellular carcinoma. Pharmacological inhibition of hepatocellular carcinoma pathogenesis and other cancers by microRNAs are now in clinical trials despite the challenges of identifying efficient microRNAs candidates and safe delivery vehicles. The focus of this review is on the interplay mechanisms between microRNAs and canonical Wnt signaling pathway in hepatocellular carcinoma, and a deep understanding of the crosstalk will promote to develop a better management of this disease.

Citing Articles

The Role of Wnt3a/β-Catenin/TCF7L2 Pathway in Diabetes and Cardiorenal Complications.

Adeerjiang Y, Sidike A, Gan X, Li Q, Jiang S Cardiorenal Med. 2024; 15(1):72-82.

PMID: 39709946 PMC: 11844670. DOI: 10.1159/000543145.

An Insight into the Arising Role of MicroRNAs in Hepatocellular Carcinoma: Future Diagnostic and Therapeutic Approaches.

Koustas E, Trifylli E, Sarantis P, Papadopoulos N, Papanikolopoulos K, Aloizos G Int J Mol Sci. 2023; 24(8).

PMID: 37108330 PMC: 10138911. DOI: 10.3390/ijms24087168.

Upscaling human mesenchymal stromal cell production in a novel vertical-wheel bioreactor enhances extracellular vesicle secretion and cargo profile.

Jeske R, Liu C, Duke L, Canonicco Castro M, Muok L, Arthur P Bioact Mater. 2023; 25:732-747.

PMID: 37056276 PMC: 10087597. DOI: 10.1016/j.bioactmat.2022.07.004.

Integrated analysis of necroptosis-related genes for evaluating immune infiltration and colon cancer prognosis.

Yang W, Lu S, Peng L, Zhang Z, Zhang Y, Guo D Front Immunol. 2023; 13:1085038.

PMID: 36618366 PMC: 9814966. DOI: 10.3389/fimmu.2022.1085038.

The AGMK1-9T7 cell model of neoplasia: Evolution of DNA copy-number aberrations and miRNA expression during transition from normal to metastatic cancer cells.

Lewis Jr A, Thomas R, Breen M, Peden K, Teferedegne B, Foseh G PLoS One. 2022; 17(10):e0275394.

PMID: 36279283 PMC: 9591059. DOI: 10.1371/journal.pone.0275394.

References

Liu X, Li J, Yu Z, Li J, Sun R, Kan Q . miR-935 Promotes Liver Cancer Cell Proliferation and Migration by Targeting SOX7. Oncol Res. 2016; 25(3):427-435. PMC: 7841071. DOI: 10.3727/096504016X14747300207374. View

Leung W, He M, Chan A, Law P, Wong N . Wnt/β-Catenin activates MiR-183/96/182 expression in hepatocellular carcinoma that promotes cell invasion. Cancer Lett. 2015; 362(1):97-105. DOI: 10.1016/j.canlet.2015.03.023. View

Thompson M, Monga S . WNT/beta-catenin signaling in liver health and disease. Hepatology. 2007; 45(5):1298-305. DOI: 10.1002/hep.21651. View

Chen X, Zhang L, Zhang T, Hao M, Zhang X, Zhang J . Methylation-mediated repression of microRNA 129-2 enhances oncogenic SOX4 expression in HCC. Liver Int. 2013; 33(3):476-86. DOI: 10.1111/liv.12097. View

Klingenberg M, Matsuda A, Diederichs S, Patel T . Non-coding RNA in hepatocellular carcinoma: Mechanisms, biomarkers and therapeutic targets. J Hepatol. 2017; 67(3):603-618. DOI: 10.1016/j.jhep.2017.04.009. View

Kuyvenhoven J, van Hoek B, Blom E, van Duijn W, Hanemaaijer R, Verheijen J . Assessment of the clinical significance of serum matrix metalloproteinases MMP-2 and MMP-9 in patients with various chronic liver diseases and hepatocellular carcinoma. Thromb Haemost. 2003; 89(4):718-25. View

Cui H, Song R, Wu J, Wang W, Chen X, Yin J . MicroRNA-337 regulates the PI3K/AKT and Wnt/β-catenin signaling pathways to inhibit hepatocellular carcinoma progression by targeting high-mobility group AT-hook 2. Am J Cancer Res. 2018; 8(3):405-421. PMC: 5883092. View

Xu X, Chen W, Miao R, Zhou Y, Wang Z, Zhang L . miR-34a induces cellular senescence via modulation of telomerase activity in human hepatocellular carcinoma by targeting FoxM1/c-Myc pathway. Oncotarget. 2015; 6(6):3988-4004. PMC: 4414168. DOI: 10.18632/oncotarget.2905. View

Bae H, Jung K, Eun J, Shen Q, Kim H, Park S . MicroRNA-221 governs tumor suppressor HDAC6 to potentiate malignant progression of liver cancer. J Hepatol. 2015; 63(2):408-19. DOI: 10.1016/j.jhep.2015.03.019. View

10.

Chen S, He Y, Ding J, Jiang Y, Jia S, Xia W . An insertion/deletion polymorphism in the 3' untranslated region of beta-transducin repeat-containing protein (betaTrCP) is associated with susceptibility for hepatocellular carcinoma in Chinese. Biochem Biophys Res Commun. 2009; 391(1):552-6. DOI: 10.1016/j.bbrc.2009.11.096. View

11.

Shen G, Jia H, Tai Q, Li Y, Chen D . miR-106b downregulates adenomatous polyposis coli and promotes cell proliferation in human hepatocellular carcinoma. Carcinogenesis. 2012; 34(1):211-9. DOI: 10.1093/carcin/bgs320. View

12.

Bienz M, Clevers H . Linking colorectal cancer to Wnt signaling. Cell. 2000; 103(2):311-20. DOI: 10.1016/s0092-8674(00)00122-7. View

13.

Chen Z, Ma T, Huang C, Zhang L, Lv X, Xu T . MiR-27a modulates the MDR1/P-glycoprotein expression by inhibiting FZD7/β-catenin pathway in hepatocellular carcinoma cells. Cell Signal. 2013; 25(12):2693-701. DOI: 10.1016/j.cellsig.2013.08.032. View

14.

Arii S, Mise M, Harada T, Furutani M, Ishigami S, Niwano M . Overexpression of matrix metalloproteinase 9 gene in hepatocellular carcinoma with invasive potential. Hepatology. 1996; 24(2):316-22. DOI: 10.1053/jhep.1996.v24.pm0008690399. View

15.

Zhang T, Liu W, Zeng X, Jiang N, Fu B, Guo Y . Down-regulation of microRNA-338-3p promoted angiogenesis in hepatocellular carcinoma. Biomed Pharmacother. 2016; 84:583-591. DOI: 10.1016/j.biopha.2016.09.056. View

16.

Xu J, Zhu X, Wu L, Yang R, Yang Z, Wang Q . MicroRNA-122 suppresses cell proliferation and induces cell apoptosis in hepatocellular carcinoma by directly targeting Wnt/β-catenin pathway. Liver Int. 2012; 32(5):752-60. DOI: 10.1111/j.1478-3231.2011.02750.x. View

17.

Zhang Y, Guo X, Li Z, Li B, Li Z, Li R . A systematic investigation based on microRNA-mediated gene regulatory network reveals that dysregulation of microRNA-19a/Cyclin D1 axis confers an oncogenic potential and a worse prognosis in human hepatocellular carcinoma. RNA Biol. 2015; 12(6):643-57. PMC: 4615594. DOI: 10.1080/15476286.2015.1022702. View

18.

Ma Y, She X, Ming Y, Wan Q . miR-24 promotes the proliferation and invasion of HCC cells by targeting SOX7. Tumour Biol. 2014; 35(11):10731-6. DOI: 10.1007/s13277-014-2018-6. View

19.

Drakaki A, Hatziapostolou M, Polytarchou C, Vorvis C, Poultsides G, Souglakos J . Functional microRNA high throughput screening reveals miR-9 as a central regulator of liver oncogenesis by affecting the PPARA-CDH1 pathway. BMC Cancer. 2015; 15:542. PMC: 4512159. DOI: 10.1186/s12885-015-1562-9. View

20.

Zhang Y, Zheng D, Xiong Y, Xue C, Chen G, Yan B . miR-202 suppresses cell proliferation in human hepatocellular carcinoma by downregulating LRP6 post-transcriptionally. FEBS Lett. 2014; 588(10):1913-20. DOI: 10.1016/j.febslet.2014.03.030. View